Washington D.C., Apr 16, 2021 / 15:15 pm
The National Institutes of Health (NIH) on Friday reversed restrictions on federally-funded research using fetal tissue and organs of aborted babies.
The Department of Health and Human Services (HHS) said in a notice to the “extramural research community” – researchers who are not at NIH facilities – that it would be removing the Trump administration’s 2019 requirement that a federal ethics advisory board review all proposals for fetal tissue research.
The administration will also revoke the previous moratorium on fetal tissue research at NIH facilities.
Tom McClusky, president of March for Life Action, called the announcement “very disappointing.”
“This type of experimental research is a gross violation of human dignity and is not where the majority of Americans want their tax dollars being spent. The government has no business creating a marketplace for aborted baby body parts,” he said.
In a statement, NIH said that HHS Secretary Xavier Becerra "determined there are no new ethical issues that require special review."
"Moving forward, NIH will manage and oversee research using human fetal tissue according to policies and procedures that were in place prior to the publication of the June 5, 2019, HHS Statement," NIH said.
Other applicable regulations and laws remain in effect, including informed consent requirements and laws prohibiting the profit from the sale of fetal tissue.